TEMPUS

There’s no need to share Soros’s pain with Smith & Nephew

Knee and hip surgeries were halted this year, but as they resumed revenues responded at Smith & Nephew
Knee and hip surgeries were halted this year, but as they resumed revenues responded at Smith & Nephew
GETTY IMAGES

If George Soros’s London investments unit did, indeed, place a large bet against Smith & Nephew’s share price last month, it’s likely to be regretting that decision now (Miles Costello writes). Shares in the medical equipment maker have rebounded strongly since then, meaning that, unless it exited its short position in time, SFM UK Management will be sitting on a sizeable loss.

It should be said that official filings to the Financial Conduct Authority do not show a disclosable short position in Smith & Nephew for SFM UK Management and the company could not be reached for comment. In truth, though, however well-known the 90-year-old billionaire investor is, what matters more to Smith & Nephew’s wider shareholder base is whether the bear case that inspired